ZNF711 and neoplasm: PR−/ER− cases demonstrated frequent loss of LNX1 and SNORA80A, and gain of ZNF4, STK24 and CCDC191; gain of CDK20 was common in PR-high tumours (Supplementary Tables 1 and 2).